Relevance to other NICE programmes

Relevance to other NICE programmes

The beclometasone/formoterol/glycopyrronium triple-therapy inhaler was not considered appropriate for a NICE technology appraisal and is not currently planned into any other NICE work programme.

In 2010, NICE published a clinical guideline on chronic obstructive pulmonary disease (NICE guideline CG101), which has been incorporated into a NICE interactive flowchart on COPD. The guideline is currently being updated (expected publication date November 2018).